Benzodiazepine use, misuse, and abuse: A review
Open accessThe DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
Benzodiazepine (BZD) abuse has reached epidemic levels and results in poor outcomes, particularly when combined with concomitant central nervous system depressants. BZDs are abused most commonly in combination with opioids and alcohol. Emergency department visits and related deaths have soared in recent years. In the absence of other medications or illicit substances, BZDs are rarely the sole cause of death. Prescription drug abuse has received more attention in recent years, yet much remains unknown about BZD abuse. BZDs have low abuse potential in most of the general population. A subset is at elevated risk of abuse, especially those with a history of a substance use disorder. Education, prevention, and identification are vital in reducing BZD abuse.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Conway, K. P., Compton, W., Stinson, F. S., & Grant, B. F. (2006) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v67n0211 · Cited by 934 · cited 1×
“use disorders.(12,15,23,24) Comorbid psychiatric disorders are more common in BZD abusers than in other substance abuse populations.”
BackgroundBenzodiazepine Use in the United States
Olfson, M., King, M., & Schoenbaum, M. (2015) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2014.1763 · Cited by 786
Polydrug abuse: a review of opioid and benzodiazepine combination use
Jones, J. D., Mogali, S., & Comer, S. D. (2012) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2012.07.004 · Cited by 703
Emergency Department Visits and Overdose Deaths From Combined Use of Opioids and Benzodiazepines
Jones, C. M., & McAninch, J. K. (2015) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2015.03.040 · Cited by 376
Lack of Relationship Between Long-Term Use of Benzodiazepines and Escalation to High Dosages
Soumerai, S. B., Simoni-Wastila, L., Singer, C., Mah, C., Gao, X., Salzman, C., & Ross-Degnan, D. (2003) · Psychiatric Services · doi:10.1176/appi.ps.54.7.1006 · Cited by 104 · cited 2×
“2 times greater risk for escalation to high doses of BZDs in comparison with other long-term BZD users.(9) Doctor shoppers or individuals visiting 4 or more clinicians in a 6-month period are more likely to be female and have 2 times the risk of drug-related death compared with nonshoppers.”
BackgroundOrzack, M. H., Friedman, L., Dessain, E., Bird, M., Beake, B., McEachern, J., & Cole, J. O. (1988) · International Journal of the Addictions · doi:10.3109/10826088809039211 · Cited by 34 · cited 1×
“Blinded recreational drug users perceived diazepam to be more valuable than equipotent doses of alprazolam and lorazepam.(47) Nevertheless, alprazolam and clonazepam are the two BZDs associated with the most abuse-related ED visits; the rate of alprazolam involvement is more than double that of clonazepam.”
BackgroundRacial Disparities in Access After Regulatory Surveillance of Benzodiazepines
Pearson, S.-A., Soumerai, S., Mah, C., Zhang, F., Simoni-Wastila, L., Salzman, C., Cosler, L. E., Fanning, T., Gallagher, P., & Ross-Degnan, D. (2006) · Archives of Internal Medicine · doi:10.1001/archinte.166.5.572 · Cited by 34
Cited by
Clayton, A. H., Lasser, R., Parikh, S. V., Iosifescu, D. V., Jung, J., Kotecha, M., Forrestal, F., Jonas, J., Kanes, S. J., & Doherty, J. (2023) · American Journal of Psychiatry · doi:10.1176/appi.ajp.20220459 · Cited by 87
Racial-Ethnic Disparities in Benzodiazepine Prescriptions for Anxiety in US Emergency Departments
Ribas Roca, J., Everett, T., Dongarwar, D., & Salihu, H. M. (2023) · Journal of Racial and Ethnic Health Disparities · doi:10.1007/s40615-021-01224-z · Cited by 11
“While physicians may be cautious to prescribe benzodiazepines to patients with a history of substance use disorder [13], the underlying racial bias of providers may impact their prescription trends if they consciously or unconsciously associate inappropriate drug use with African American patients [7] despite the exis…”
BackgroundSartori, S., Crescioli, G., Brilli, V., Traversoni, S., Lanzi, C., Vannacci, A., Mannaioni, G., & Lombardi, N. (2022) · Internal and Emergency Medicine · doi:10.1007/s11739-022-02976-0 · Cited by 11
“For the above reasons, discontinuing sedativehypnotic medications should be considered after prolonged use, especially if used improperly or abused [5].”
Metadata
- Authors
- Schmitz, A.
- Venue
- Mental Health Clinician
- Published
- 2016-05
- Volume
- 6
- Issue
- 3
- Pages
- 120-126
- ISSN
- 2168-9709 (ISSN-L)
- OpenAlex
- W2346174592
- Cited by
- 186
- References
- 7
- FWCI
- 3.93
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.